My understanding is the TAVR device sells for approximately $30k so the estimate for 2025 would therefore be 400k procedures. The US have estimated 90m patients could benefit from this procedure in their country alone.
I assume this below statement is all in costs.
The global Transcatheter Aortic Valve Implantation (TAVI) procedures market size is anticipated to reach USD 26.3 billion by 2025
https://www.prnewswire.com/news-rel...ation-tavrtavi-market-to-2025--300699322.html
Ann: Promising Interim Results from TAVR Animal Study, page-17
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |